BZAM’s Medical Cannabis Products To Reach UK Market Via 4C LABS – BZAM (OTC:BZAMF)

BZAM Ltd. BZAMF BZAM announced that its subsidiary, The Green Organic Dutchman Ltd. has entered into a strategic distribution agreement with 4C LABS Ltd. The company and 4C LABS expect to commercialize medical cannabis products under The Green Organic Dutchman brand in the UK beginning in Q4 2023.

Pursuant to the agreement, signed on April 29, 2023, the company will supply 4C LABS with approximately 600kg of flower annually for the next two years.

The company is a certified organic grower of medical cannabis in living soil. The company recently received EU GMP certification for its greenhouse facility located in Ancaster, Ontario, Canada. This certification permits the company to export certain medical cannabis products to numerous global markets, including the UK.

Matt Milich, BZAM’s CEO, stated: “We are proud to announce this agreement with 4C LABS to bring our exceptional product to the UK market. Executing on our recent EU GMP Certification is a key priority and we are excited to be able to partner with local experts like 4C LABS.”

Greg Dobbin, 4C LABS CEO, stated: “We are extremely pleased to be able to offer The Green Organic Dutchman products to our UK patients. BZAM is a world class company which operates a truly innovative facility where Canada’s best growers and unique genetics come together. From feeding certain plants maple syrup to creating community gardens at their grow facility, the BZAM team takes medical cannabis to the next level.”

Photo: Benzinga edit with photos by geralt and lindsayfox on Pixabay

Related News

This Cannabis Company Chairman Is Betting On It! Plans To Invest Extra $3.7M In The Business

BZAM Announces Shares For Debt Transaction And Stock Option Grants

BZAM FY22 Revenue Grows 63%, What About Profit?

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *